Home > Insider Trading > Filing (0001104659-19-071931)

Filing Details

Accession Number:: 0001104659-19-071931
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-12-11 18:54:52
Reporting Period:: 2019-12-09

Accepted Time:: 2019-12-11 18:54:52
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1410939	Iveric Bio Inc.	ISEE	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1277478	Glenn Sblendorio	C/O Iveric Bio, Inc. One Penn Plaza, 35Th Floor New York NY 10119	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-12-10	62,500	$4.00	176,854	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2019-12-09	190,000	$0.00	190,000	$5.22
Common Stock	Restricted Stock Units	Acquisiton	2019-12-09	95,000	$0.00	95,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
190,000		2029-12-08	No	4	A	Direct
95,000			No	4	A	Direct

Footnotes

These shares were acquired in a public offering of the Registrant of shares of the Registrant's common stock. The public offering price of the shares of common stock was $4.000 per share.
Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the stock option award will vest as follows: (1) no shares underlying the option shall vest unless, for a period of twenty consecutive trading days, the average closing sale price of the Registrant's common stock is equal to or exceeds 125% of the exercise price per share of such option (the "Performance Condition"), (2) subject to satisfaction of the Performance Condition, the option shall vest with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in equal monthly installments through the fourth anniversary of the grant date, and (3) such stock option shall be subject to "double-trigger" acceleration of vesting upon termination of employment following a change in control of the Registrant.
Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of restricted stock units will vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date.